Edition:
United States

Pharmaceuticals

In first phase 3 trial Merck's virus vaccine (V2120 reduced the incidence of confirmed herpes zoster cases

Merck & Co Inc : In first phase 3 trial, Merck's investigational inactivated varicella zoster virus vaccine (V212) reduced the incidence of confirmed herpes zoster cases by an estimated 64 percent in immunocompromised subjects . Merck & Co Inc - in trial, V212 met its primary endpoint . Merck & Co...

Friday, 24 Feb 2017 04:00pm EST

FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi

U.S. Federal Trade Commission (FTC) :U.S. FTC - Approved final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Sanofi would likely be anticompetitive.

Friday, 24 Feb 2017 01:47pm EST

FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi

U.S. Federal Trade Commission (FTC) :U.S. FTC - Approved final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Sanofi would likely be anticompetitive.

Friday, 24 Feb 2017 01:47pm EST

Pfizer announces pricing of $1.07 bln debt offering

Pfizer Inc : Pfizer prices $1,065,000,000 debt offering . Pfizer Inc says pricing of $1.07 billion aggregate principal amount of 4.20% notes due 2047 . Offering is expected to be sold to professional institutional investors in Taiwan, with application to be made to list notes on Taipei Exchange...

Friday, 24 Feb 2017 01:12pm EST

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.